Skip to main content
OpenTrials

Clinical trial condition

Skin Diseases, Papulosquamous

Explore clinical trials studying Skin Diseases, Papulosquamous. Study availability and eligibility vary by location and protocol.

1,740 public trials 205 recruiting studies
Refine in advanced search Browse all conditions

Skin Diseases, Papulosquamous trial results

Recruiting

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis

NCT06425549

Conditions
Moderate to Severe Plaque Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations
  • Ps0021 50162 Fountain Valley, California, United States
  • Ps0021 50161 Los Angeles, California, United States
  • Ps0021 50196 Northridge, California, United States
  • Ps0021 50581 Miami, Florida, United States
View all 50 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis

NCT07219420

Conditions
Aggressive Periodontitis, Mouth Diseases, Palmoplantar Pustulosis, +7 more
Locations
  • Ppp001 50754 Birmingham, Alabama, United States
  • Ppp001 50746 Coral Gables, Florida, United States
  • Ppp001 50757 Auburn Hills, Michigan, United States
  • Ppp001 50745 Columbus, Ohio, United States
View all 87 locations
View Trial Details
Recruiting

A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

NCT06888193

Conditions
Ankylosis, Arthritis, Arthritis, Psoriatic, +23 more
Locations
  • Up0122 105 Santa Monica, California, United States
  • Up0122 103 South Miami, Florida, United States
  • Up0122 104 Boston, Massachusetts, United States
  • Up0122 106 Chapel Hill, North Carolina, United States
View all 14 locations
View Trial Details
Recruiting

Modifying PEST for Psoriatic Arthritis Screening

NCT06382051

Conditions
Arthritis, Arthritis, Psoriatic, Bone Diseases, +12 more
Locations
  • Novartis Investigative Site Calgary, Alberta, Canada
  • Novartis Investigative Site Edmonton, Alberta, Canada
  • Novartis Investigative Site Edmonton, Alberta, Canada
  • Novartis Investigative Site Kelowna, British Columbia, Canada
View all 30 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

NCT06979453

Conditions
Exanthema, Pathological Conditions, Signs and Symptoms, Plaque Psoriasis, +7 more
Locations
  • Local Institution - 0261 Birmingham, Alabama, United States
  • Local Institution - 0041 Birmingham, Alabama, United States
  • Local Institution - 0053 Phoenix, Arizona, United States
  • Local Institution - 0025 Fountain Valley, California, United States
View all 129 locations
View Trial Details
Recruiting

Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response

NCT06641089

Conditions
Arthritis, Arthritis, Psoriatic, Bone Diseases, +10 more
Locations
  • Clinical Site Avondale, Arizona, United States
  • Clinical Site Chandler, Arizona, United States
  • Clinical Site Flagstaff, Arizona, United States
  • Clinical Site Mesa, Arizona, United States
View all 139 locations
View Trial Details
Recruiting

A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis

NCT07489885

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • Study Center Birmingham, Alabama, United States
  • Study Center Phoenix, Arizona, United States
  • Study Center Chula Vista, California, United States
  • Study Center Fountain Valley, California, United States
View all 20 locations
View Trial Details

Related conditions